Lianbo Wei

892 total citations
33 papers, 731 citations indexed

About

Lianbo Wei is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Lianbo Wei has authored 33 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Nephrology and 7 papers in Epidemiology. Recurrent topics in Lianbo Wei's work include Renal Diseases and Glomerulopathies (6 papers), Traditional Chinese Medicine Analysis (4 papers) and Autophagy in Disease and Therapy (4 papers). Lianbo Wei is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Traditional Chinese Medicine Analysis (4 papers) and Autophagy in Disease and Therapy (4 papers). Lianbo Wei collaborates with scholars based in China. Lianbo Wei's co-authors include Lu Lu, Ming Wang, Rong Hu, Haiyan You, Xiaohui Wu, Mingqing Wang, Lingyu Liu, Yi Yin, Shi-Hao Ni and Mingqing Wang and has published in prestigious journals such as Journal of Ethnopharmacology, European Journal of Pharmacology and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Lianbo Wei

33 papers receiving 719 citations

Peers

Lianbo Wei
Yong Su China
Yun‐Ho Kim South Korea
Flori R. Sari Japan
Yunman Wang China
Shunmin Li China
Jiangyi Yu China
Hengjiang Guo China
Xin Qin China
Lin-Lin Kang China
Yong Su China
Lianbo Wei
Citations per year, relative to Lianbo Wei Lianbo Wei (= 1×) peers Yong Su

Countries citing papers authored by Lianbo Wei

Since Specialization
Citations

This map shows the geographic impact of Lianbo Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianbo Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianbo Wei more than expected).

Fields of papers citing papers by Lianbo Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianbo Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianbo Wei. The network helps show where Lianbo Wei may publish in the future.

Co-authorship network of co-authors of Lianbo Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Lianbo Wei. A scholar is included among the top collaborators of Lianbo Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianbo Wei. Lianbo Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Mingqing, Lianbo Wei, Zhixuan Li, et al.. (2022). Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study. Frontiers in Oncology. 12. 893183–893183. 13 indexed citations
2.
Hu, Rong, Mingqing Wang, Shi-Hao Ni, et al.. (2019). Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs. European Journal of Pharmacology. 867. 172797–172797. 161 indexed citations
3.
Wei, Lianbo & Lingyu Liu. (2018). Toxic and side effects of rhubarb and its reasonable application in kidney diseases. 7(1). 13–16. 1 indexed citations
4.
Wang, Dongtao, Lianbo Wei, Yajun Yang, & Huan Liu. (2018). Dietary supplementation with ketoacids protects against CKD-induced oxidative damage and mitochondrial dysfunction in skeletal muscle of 5/6 nephrectomised rats. Skeletal Muscle. 8(1). 18–18. 31 indexed citations
5.
Zhong, Liang, et al.. (2017). Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention. Journal of International Medical Research. 45(2). 792–797. 20 indexed citations
6.
Lu, Lu, Yanfeng Huang, Ming Wang, et al.. (2016). Astragalus polysaccharides decrease muscle wasting through Akt/mTOR, ubiquitin proteasome and autophagy signalling in 5/6 nephrectomised rats. Journal of Ethnopharmacology. 186. 125–135. 38 indexed citations
7.
Huang, Yanfeng, Lu Lu, Dajian Zhu, et al.. (2016). Effects of Astragalus Polysaccharides on Dysfunction of Mitochondrial Dynamics Induced by Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2016(1). 9573291–9573291. 55 indexed citations
8.
Gong, Wangqiu, Lu Lu, Jing Chen, et al.. (2016). Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-γ, AMPK/Akt/mTOR signaling and autophagy. International Immunopharmacology. 42. 176–184. 60 indexed citations
9.
Liu, Jun-Shan, Lu Lu, Yanfeng Huang, et al.. (2016). Emodin attenuates TNF-α-induced apoptosis and autophagy in mouse C2C12 myoblasts though the phosphorylation of Akt. International Immunopharmacology. 34. 107–113. 37 indexed citations
10.
11.
Lu, Lu, Xiaoming Sun, Yi Yin, et al.. (2015). The amino acid mutations of the podocin in proteinuria: a meta-analysis. Renal Failure. 37(8). 1329–1337. 3 indexed citations
12.
Yin, Yi, Lu Lu, Dongtao Wang, et al.. (2015). Astragalus Polysaccharide Inhibits Autophagy and Apoptosis from Peroxide-Induced Injury in C2C12 Myoblasts. Cell Biochemistry and Biophysics. 73(2). 433–439. 20 indexed citations
13.
Wang, Ming, et al.. (2015). Sparstolonin B inhibits lipopolysaccharide-induced inflammation in 3T3-L1 adipocytes. European Journal of Pharmacology. 769. 79–85. 32 indexed citations
14.
Shi, Ying, Liming Xiao, Yi Yin, & Lianbo Wei. (2014). Ligustilide inhibits tumour necrosis factor-alpha-induced autophagy during C2C12 cells differentiation. Biomedicine & Pharmacotherapy. 69. 42–46. 19 indexed citations
15.
Lu, Lu, Heng Wan, Yi Yin, et al.. (2014). The p.R229Q variant of the NPHS2 (podocin) gene in focal segmental glomerulosclerosis and steroid-resistant nephrotic syndrome: a meta-analysis. International Urology and Nephrology. 46(7). 1383–1393. 7 indexed citations
16.
Shi, Ying, Dongtao Wang, Lu Lu, et al.. (2014). Ligustilide prevents the apoptosis effects of tumour necrosis factor-alpha during C2C12 cell differentiation. International Immunopharmacology. 19(2). 358–364. 14 indexed citations
17.
Wang, Yongjun, Liqun He, Wei Sun, et al.. (2011). Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: A multicenter double-blinded randomized controlled trial. Journal of Ethnopharmacology. 139(3). 757–764. 52 indexed citations
18.
Long, Haibo, et al.. (2010). [Effects of Shenkangwan on renal expressions of angiotensin II and its type I receptor in rats with early diabetic nephropathy].. PubMed. 30(4). 805–9. 2 indexed citations
19.
Chen, Guobao, Lianbo Wei, Wei Xiao, & Haibo Long. (2006). [Effect of Shenkangwan on mesangial cell NO and TGF-beta1 excretion in rats with early diabetic nephropathy].. PubMed. 26(4). 526–8. 1 indexed citations
20.
Wei, Lianbo, et al.. (2002). Long-term effect of TCM decoctions in treatment of nephrotic syndrome.. PubMed. 22(2). 83–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong Su Breakdown of academic impact, for papers by Yun‐Ho Kim Breakdown of academic impact, for papers by Flori R. Sari Breakdown of academic impact, for papers by Yunman Wang Breakdown of academic impact, for papers by Shunmin Li Breakdown of academic impact, for papers by Jiangyi Yu Breakdown of academic impact, for papers by Hengjiang Guo Breakdown of academic impact, for papers by Xin Qin Breakdown of academic impact, for papers by Lin-Lin Kang
Rankless by CCL
2026